NCT03208582View on ClinicalTrials.gov

Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

November 2, 2017

Study Completion Date

November 2, 2017

Conditions
Osteogenesis Imperfecta
Interventions
DRUG

Risedronate Sodium

Participants will be initially tested on the response to mechanical stimulation as a baseline and then tested again after 6 weeks treatment with Risedronate

DIETARY_SUPPLEMENT

Calcichew tablets

Participants will take calcichew tablets during the 6 week period of risedronate treatment

Trial Locations (1)

S10 2TH

Clinical Research Facility, Sheffield

All Listed Sponsors
lead

Sheffield Children's NHS Foundation Trust

OTHER

NCT03208582 - Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta? | Biotech Hunter | Biotech Hunter